Since its introduction in the early nineties as a promising functional imaging technique in the
management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has …

Background The identification of surgical non-small cell lung cancer (NSCLC) patients with
poor prognosis is a priority in clinical oncology because of their high 5-year mortality. This …

PURPOSE: To analyze the long-term survival and tumor control outcomes after stereotactic
body radiotherapy (SBRT) for metastases limited in number and extent. METHODS AND …

Purpose We conducted a comprehensive systematic review of the literature on volumetric
parameters from 18 F-FDG PET and a meta-analysis of the prognostic value of metabolic …

Purpose The objective of this study was to assess the prognostic value of metabolic tumor
burden on 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG) positron emission tomography …

Purpose To determine whether whole-body total lesion glycolysis (TLG), which combines
volumetric and metabolic information from fluorine 18 fluorodeoxyglucose (FDG) positron …

18F-FDG metabolic tumor volume (MTV) and total glycolytic activity (TGA) have been
proposed as potential prognostic imaging markers for patient outcome in human solid …

Introduction Few validated prognostic factors are available for survival in patients with lung
cancer.[18 F]-fluoro-2-deoxy-d-glucose positron emission tomography has been shown to …

Purpose In this prospective National Cancer Institute–funded American College of
Radiology Imaging Network/Radiation Therapy Oncology Group cooperative group trial, we …

Purpose The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is a predictor
of a poor outcome. The total metabolic tumour volume at baseline (TMTV0) computed on …